Pulmonary anthrax
ICD-10 A22.0 is a billable code used to indicate a diagnosis of pulmonary anthrax.
Pulmonary anthrax is a severe infectious disease caused by the bacterium Bacillus anthracis, primarily affecting the lungs. It is classified as a zoonotic infection, meaning it can be transmitted from animals to humans. The disease typically occurs when spores of the bacterium are inhaled, leading to a rapid onset of symptoms such as fever, cough, chest pain, and severe respiratory distress. The initial symptoms may resemble those of a common cold or flu, but can quickly progress to severe pneumonia and systemic shock. Pulmonary anthrax is often associated with occupational exposure, particularly in individuals who work with animal products, such as wool or hides, or in agricultural settings where livestock may be infected. Public health considerations are critical, as anthrax can be used as a biological weapon, necessitating surveillance and preparedness measures. Vaccination is available for high-risk populations, and prompt treatment with antibiotics is essential for improving outcomes in infected individuals.
Detailed patient history including exposure to animals, travel history, and symptom onset.
Diagnosis of pulmonary anthrax in patients with respiratory symptoms and known exposure to livestock.
Ensure thorough documentation of clinical findings and laboratory results to support the diagnosis.
Reporting of cases to health authorities, including exposure details and demographic information.
Investigation of anthrax outbreaks in agricultural communities.
Collaboration with epidemiologists for accurate tracking and reporting.
Used when confirming a diagnosis of pulmonary anthrax.
Document the source of the culture and clinical indications.
Infectious disease specialists should ensure proper specimen handling.
Symptoms include fever, cough, chest pain, and difficulty breathing, which can progress rapidly.
It is primarily transmitted through inhalation of spores from contaminated animal products or environments.